An Update on Familial Hyperaldosteronism.

Area of Science:

• Endocrinology
• Genetics
• Molecular Biology

Background:

• Familial primary aldosteronism (PA) accounts for a significant portion of cases in specialized centers.
• The genetic underpinnings of familial PA were largely unknown, except for glucocorticoid-remediable aldosteronism.
• Recent advancements have identified mutations in several genes contributing to familial PA.

Purpose of the Study:

• To review and summarize the current understanding of genetic mutations causing familial primary aldosteronism.
• To highlight the discovery of novel gene mutations implicated in PA inheritance.
• To discuss the implications of these genetic findings for diagnosing and understanding PA.

Main Methods:

• Review of recent genetic studies and exome/genome sequencing data.
• Analysis of identified germline mutations in genes such as KCNJ5, CACNA1D, and CACNA1H.
• Correlation of genetic findings with clinical phenotypes of primary aldosteronism.

Main Results:

• Gain-of-function mutations in KCNJ5 (potassium channel) cause autosomal dominant PA and hypertension.
• Mutations in CACNA1D (L-type calcium channel) are linked to PA, seizures, and neurological issues.
• Germline mutations in CACNA1H (T-type calcium channel) identified in families with early-onset PA and hypertension.

Conclusions:

• Genetic discoveries, particularly in KCNJ5, CACNA1D, and CACNA1H, are rapidly expanding the known causes of familial primary aldosteronism.
• Identification of these mutations provides crucial insights into the molecular mechanisms underlying PA.
• Future genomic studies are essential to unravel the genetic basis of remaining unexplained familial hyperaldosteronism cases.